Logotype for Nanoform Finland

Nanoform Finland (NANOFH) investor relations material

Nanoform Finland Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Nanoform Finland
Q3 2025 earnings summary12 Nov, 2025

Executive summary

  • Granted a commercial cGMP manufacturing license, enabling production and quality control of nanoformed APIs for Europe and other markets, and achieved significant progress in scaling both small molecule and biologics platforms.

  • Expanded product kernel pipeline with new nanoformulated therapies, including partnerships for nanoencorafenib and a combination of olaparib/temozolomide, and advanced clinical and licensing stages.

  • Announced Asia expansion with partnerships in Japan and South Korea, strengthening commercial presence.

  • All 2025 near-term business targets remain on track, with a new 2026 target for cash burn below EUR 10 million and CMD set for December 16 to announce 2030 mid-term targets.

  • Cash burn improved due to lower costs and higher customer payments, with strong cash position at period end.

Financial highlights

  • Revenue for 1-9/2025 grew 9% year-over-year to EUR 2.2 million from 45 customer projects, with gross profit up to EUR 1.9 million and gross margin at 86%.

  • Quarterly cash burn reduced to EUR 3.9 million in Q3 2025, with annualized cash burn at approximately minus EUR 15 million.

  • Cash and cash equivalents at end of Q3 2025 were EUR 29.5 million, supporting a strong balance sheet.

  • EBITDA improved to EUR -14.1 million, and operating loss narrowed to EUR -16.6 million.

  • Customer payments and revenues recognized in 2025 outpace 2024 levels.

Outlook and guidance

  • Targeting cash burn below EUR 10 million for 2026, with improved free cash flow anticipated in 2025 versus 2024.

  • All 2025 near-term business targets are on track, including signing new development and license agreements.

  • New 2030 mid-term targets to be announced at Capital Markets Day in December.

  • First pivotal bioequivalence clinical study with a nanoformed medicine expected.

  • Expecting an uptick in project signings as pharma industry replenishes early-stage pipelines.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Nanoform Finland earnings date

Logotype for Nanoform Finland
Q4 202526 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Nanoform Finland earnings date

Logotype for Nanoform Finland
Q4 202526 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Nanoform provides nanotechnology and drug particle engineering services for the pharmaceutical industry. The company offers nanoparticle milling, a mechanical fragmentation process that reduces the particle size of APIs and enables the development of more bioavailable formulations. In addition, it provides physical characterization services for nanoparticles that comprises morphological analysis, including atomic force microscopy and scanning electron microscopy; elemental chemical analysis comprising inductively coupled plasma optical emission spectroscopy; and particle size distribution analysis comprising dynamic light scattering and laser diffraction, as well as supporting analytical equipment. The company was founded in 2008 and is headquartered in Helsinki, Finland.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage